lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
204 rows where filing_period = "third_quarter", filing_year = 2011 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1143231 | BELL POTTINGER USA a238906b-b56d-444b-b5d0-0a72ba971ed6 | 3T | BELL POTTINGER USA | 400703108 | LEO PHARMA INC. | 2011 | third_quarter | PHA | Engage FDA, CDC and Hill policy-makers on behalf of the client to support regulatory and outreach efforts in the US. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 1 | 2011-08-12T11:46:09.650000-04:00 | |
| 1144784 | R.G. FLIPPO AND ASSOCIATES, INC 226ad98b-bd49-4579-b6cd-4d6edb68699f | Q3 | R.G. FLIPPO AND ASSOCIATES, INC | 14861 | ALABAMA NURSING HOME ASSOCIATION | 2011 | third_quarter | PHA | S. 1560 Nursing Home Resident Pain Relief Act of 2011 | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2011-10-04T15:37:07.143000-04:00 | |
| 1144788 | INDEPENDENT PHARMACY COOPERATIVE 092bc8e0-b865-4521-adde-d3347b6b560c | Q3 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2011 | third_quarter | PHA | DEA Physician/Nurse Agent Definition. CMS Average Acquisition Cost (AAC) Methodology. S. 274 The Medication Management Empowerment Act of 2011. All provisions S. 1002 Prohibit Theft of Medical Products 2011. All provisions | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-04T16:02:15.797000-04:00 | |
| 1144796 | AMERICAN FOUNDATION FOR THE BLIND bab1a9b7-308d-40e7-b0d1-845d7431a8d0 | Q3 | AMERICAN FOUNDATION FOR THE BLIND | 2401 | AMERICAN FOUNDATION FOR THE BLIND | 2011 | third_quarter | PHA | Prescription Drug labeling | Federal Communications Commission (FCC),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-04T16:40:23.753000-04:00 | ||
| 1144846 | AMERICAN COLLEGE OF CLINICAL PHARMACY 34947c73-2a84-4032-9ca2-13ecde8cf4b2 | Q3 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2011 | third_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 59600 | 0 | 0 | 2011-10-05T09:52:10.183000-04:00 | |
| 1144879 | CYBER SECURITY RESEARCH CONSULTANTS, LLC 26a4dab1-dd02-457b-9bc3-5d9ad5e38cb5 | Q3 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2011 | third_quarter | PHA | Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug Reimportation from Canada Monitoring Protect IP Act | HOUSE OF REPRESENTATIVES,SENATE | 21000 | 0 | 0 | 2011-10-05T11:08:34.337000-04:00 | |
| 1144892 | MEREDITH MCGEHEE 49dabc70-d848-4060-bb8f-80ee38708b34 | 3T | MEREDITH MCGEHEE | 79858 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2011 | third_quarter | PHA | Funding for programs to develop AIDS vaccines targeted toward the developing world; Educating about research and development programs aimed at AIDS epidemic and other global health issues; Appropriations for USAID R&D and funding for IAVI; Provide information on IAVI's PDP model; Providing input regarding foreign assistance reform from global health perspective; FUnding and budget issues related to USAID R&D. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2011-10-05T11:30:42.837000-04:00 | |
| 1145161 | SHELTER ROCK STRATEGIES, LLC 61f6815a-48b2-4017-8d40-26377706818c | Q3 | SHELTER ROCK STRATEGIES, LLC | 400772326 | NEW YORK MEDICAL COLLEGE | 2011 | third_quarter | PHA | BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aid the client's proposal. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-06T10:01:15.977000-04:00 | |
| 1145165 | INJURED WORKERS PHARMACY 7138f6b7-32ec-426b-99be-daa2c2552a6e | Q3 | INJURED WORKERS PHARMACY | 400765309 | INJURED WORKERS PHARMACY | 2011 | third_quarter | PHA | Transparency of Pharmacy Benefit Managers (Bill sponosred by Rep. McMorris Rodgers and Sen. Mark Pryor; Longshoer and Harbor Workers Amendment Act of 2011 sponsored by Sen. Isakson. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-06T10:20:21.633000-04:00 | ||
| 1145485 | PARRY, ROMANI, DECONCINI & SYMMS 74d490fb-2f3f-4b79-823b-cc8bab103fb5 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | POZEN, INC. | 2011 | third_quarter | PHA | To provide incentives for new drug development. No specific bills pending. | HOUSE OF REPRESENTATIVES,SENATE | 36000 | 0 | 0 | 2011-10-07T12:41:41.980000-04:00 | |
| 1146008 | RED+BLUE STRATEGIES 9f9d403e-615b-4a80-bfac-86f149373841 | Q3 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2011 | third_quarter | PHA | H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-10-10T14:46:19.470000-04:00 | |
| 1146053 | RED+BLUE STRATEGIES 1762f489-58b5-44b4-82cb-0bce55aa72c6 | Q3 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2011 | third_quarter | PHA | H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Trade Representative (USTR) | 40000 | 0 | 0 | 2011-10-10T15:30:41.280000-04:00 | |
| 1146430 | PUBLIC AFFAIRS RESOURCES, INC. 4f9870d9-a516-404b-bb81-4a84813fe7e1 | Q3 | PUBLIC AFFAIRS RESOURCES, INC. | 31270 | PACKAGING CORPORATION OF AMERICA (PCA) (BOISE INC IS NOW A SUBSIDIARY OF PCA ) | 2011 | third_quarter | PHA | Electronic Professional Inserts in lieu of Paper, FDA | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-11T12:52:40.833000-04:00 | |
| 1146455 | THE OB-C GROUP, LLC 4dfcdcc0-13dc-4c86-8dc4-e1a5ca6b3702 | Q3 | THE OB-C GROUP, LLC | 29802 | ELI LILLY | 2011 | third_quarter | PHA | No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-11T13:20:26.393000-04:00 | |
| 1146469 | LONG TERM CARE PHARMACY ALLIANCE 0df3bcf9-262b-4f07-9772-9d4c084e5931 | Q3 | LONG TERM CARE PHARMACY ALLIANCE | 400309443 | LONG TERM CARE PHARMACY ALLIANCE | 2011 | third_quarter | PHA | Medicare Part D | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 201000 | 0 | 0 | 2011-10-11T13:42:37.050000-04:00 | |
| 1146614 | NAHIGIAN STRATEGIES, LLC 6eb4f9a6-8672-4d0e-8c8b-6307af1f1abf | Q3 | NAHIGIAN STRATEGIES, LLC | 322897 | TEVA PHARMACEUTICALS USA INC | 2011 | third_quarter | PHA | Generic Drug issues Generally | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-11T15:23:10.177000-04:00 | |
| 1146905 | ACADEMY OF MANAGED CARE PHARMACY aaf6fb28-78f1-4f01-90b5-e8ab7fc8663d | Q3 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2011 | third_quarter | PHA | S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufacturer agrees to delay entry into the market in exchange for compensation from the manufacturer of the innovator product. HR 1483 - legislation that would introduce reforms and reauthorizations of the FDA, including the prescription drug user fee act S 296 and HR 2245 - legislation that would address shortages of prescription drugs HR 2746 - legislation that would require cost-sharing parity between all cancer medications within pharmacy benefits regulated under ERISA. HR 979 - legislation that would implement transparency standards and other regulations for pharmacy benefit managers working within the Federal Employees Health Benefits Program. | HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2011-10-12T10:14:35.163000-04:00 | |
| 1147636 | NOVO NORDISK INC. f36b85f5-586c-4d2b-a5be-7fd747027a6d | Q3 | NOVO NORDISK INC. | 284790 | NOVO NORDISK INC. | 2011 | third_quarter | PHA | P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE | 910000 | 0 | 0 | 2011-10-13T10:12:23.790000-04:00 | |
| 1147704 | CAPITOL HILL CONSULTING GROUP cad5255c-e7d7-4214-93f9-007858ee09f1 | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2011 | third_quarter | PHA | Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-13T11:04:04.507000-04:00 | |
| 1147719 | DUTKO WORLDWIDE, LLC d8aab9bb-663c-4fa9-bba4-e078c2376897 | Q3 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2011 | third_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-13T11:12:12.850000-04:00 | |
| 1147779 | EXPRESS SCRIPTS, INC. 9e0066da-1d41-47fb-98d8-8e0ce3eb84c3 | Q3 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2011 | third_quarter | PHA | Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058). | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,U.S. Trade Representative (USTR),White House Office | 380000 | 0 | 0 | 2011-10-13T11:48:40.817000-04:00 | |
| 1147863 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK c28f66d8-90c2-4e0d-b3de-953ff87e2e08 | Q3 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 309377 | ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 2011 | third_quarter | PHA | Support legislation that would allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-13T12:52:23.190000-04:00 | ||
| 1147945 | BUCHANAN INGERSOLL & ROONEY PC a08b37c2-66bc-4d73-8c34-0c3287bb3e0c | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | SHIRE PHARMACEUTICALS INC | 2011 | third_quarter | PHA | Life Sciences Investment Act; ESRD bundling, ESRD Quality Incentive program; orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-13T13:16:51.163000-04:00 | |
| 1148378 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1ead4c84-5b03-4662-bb19-e80415fda570 | Q3 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 1672 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 2011 | third_quarter | PHA | the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE | 18836 | 0 | 0 | 2011-10-13T16:30:00.950000-04:00 | |
| 1149474 | FOLEY & LARDNER LLP f8628f61-0660-41d2-96ec-1d465817c7cc | Q3 | FOLEY & LARDNER LLP | 15042 | ROMARK LABORATORIES, LC | 2011 | third_quarter | PHA | Sale of new anti-viral drug | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-14T15:28:47.940000-04:00 | ||
| 1149711 | GOVBIZ ADVANTAGE, INC. 6af8645d-ea62-412b-992e-dc7eb3c76591 | Q3 | GOVBIZ ADVANTAGE, INC. | 294234 | CATALYST HEALTH SOLUTIONS (CATAMARANRX) | 2011 | third_quarter | PHA | Pharmacy Benefit Issues in health legislation; PBM issues; General company congressional relations; business issues | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-14T16:59:11.500000-04:00 | |
| 1149760 | VENABLE LLP 2432ced9-d54e-4fa4-bc33-c080648f1dbb | Q3 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2011 | third_quarter | PHA | General issues affecting the pharmaceutical industry The Life Sciences Investment Act | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-14T17:32:41.580000-04:00 | |
| 1149764 | PRIME THERAPEUTICS 8eb0c437-c1be-4815-b237-20192f83fb92 | Q3 | PRIME THERAPEUTICS | 400339576 | PRIME THERAPEUTICS | 2011 | third_quarter | PHA | HR 1946 - Preserving our Hometown Independent Pharmacies, anti-trust exemption for pharmacies HR 1971/S. 1058 - Pharmacy Competition and Consumer Choice Act, pharmacy network restrictions and audit reform | HOUSE OF REPRESENTATIVES,SENATE | 170000 | 0 | 0 | 2011-10-14T17:34:44.063000-04:00 | |
| 1150147 | HEARTLAND SOLUTIONS GROUP, INC. 912ce255-e8bd-4c79-8337-e7fef5d8a5e1 | Q3 | HEARTLAND SOLUTIONS GROUP, INC. | 312133 | ZEBRA TECHNOLOGIES CORPORATION | 2011 | third_quarter | PHA | Any and all issues related to barcode, secure identification and real-time location systems. | Army, Dept of (Other),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-10-16T18:55:25.103000-04:00 | |
| 1150864 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 011af3e5-b0d4-4a7f-95c2-7488af7a44c9 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2011 | third_quarter | PHA | Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2011-10-17T12:53:39.483000-04:00 | |
| 1150911 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3ea52269-8e4a-4232-b2f3-6227f856e7fe | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2011 | third_quarter | PHA | Issues related to drug shortages. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2011-10-17T13:02:55.513000-04:00 | |
| 1151139 | PARRY, ROMANI, DECONCINI & SYMMS 9e878fe1-f6fa-4160-ad8f-1275a08de954 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2011 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practioner acting in the usual course of professional practice. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T14:27:27.150000-04:00 | |
| 1151185 | PARRY, ROMANI, DECONCINI & SYMMS 128133c7-36ec-4fb9-8aa1-c54f21cf7ff1 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2011 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2011-10-17T14:36:45.987000-04:00 | |
| 1151206 | POLICY DIRECTIONS INC. d8ab9f4f-abe5-4c21-9526-2e9b533bbfde | Q3 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2011 | third_quarter | PHA | Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-17T14:39:55.943000-04:00 | |
| 1151422 | PARRY, ROMANI, DECONCINI & SYMMS 083d9071-19ea-483c-bfd0-464b908be417 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2011 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T15:22:15.357000-04:00 | |
| 1151452 | PARRY, ROMANI, DECONCINI & SYMMS 9b1a94b1-063d-442e-9416-24e4290aeeb5 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2011 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T15:28:25.090000-04:00 | |
| 1151514 | GREATER NEW YORK HOSPITAL ASSOCIATION 15e07a06-1019-42f8-a4d3-d5ec9f4294f4 | Q3 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2011 | third_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), medical device pricing issues, and preserving access to group purchasing organizations. | Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 240000 | 0 | 0 | 2011-10-17T15:36:42.017000-04:00 | |
| 1151516 | PARRY, ROMANI, DECONCINI & SYMMS 5d125bb2-465d-433b-bbe4-a640a626165f | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2011 | third_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T15:37:42.997000-04:00 | |
| 1151518 | THORN RUN PARTNERS 54a85fed-7611-444f-904c-8dec2e6eea2e | Q3 | THORN RUN PARTNERS | 400534596 | LONG TERM CARE PHARMACY ALLIANCE | 2011 | third_quarter | PHA | Issues related to the implementation of the Affordable Care Act (ACA) and DEA enforcement of controlled substances in nursing homes. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-17T15:37:43.653000-04:00 | |
| 1151542 | MCKENNA, LONG & ALDRIDGE d4d14ff9-e570-4256-ad85-4a6992f58918 | Q3 | MCKENNA, LONG & ALDRIDGE | 76913 | REVANCE THERAPEUTICS, INC. | 2011 | third_quarter | PHA | Any issues impacting biopharmaceutical companies | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-17T15:45:58.483000-04:00 | |
| 1151643 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 25b33942-a0bc-418e-8d74-68a1902a46ab | Q3 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2011 | third_quarter | PHA | H.R. 979, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2011, legislation to reform oversight authority for OPM for the FEHBP drug benefit; H.R. 891 and S. 274, the Medication Therapy Management Benefits Act of 2011, which would expand beneficiary access to MTM services under Part D; H.R. 1041, the Fairness in Medicare Bidding Act, this legislation would repeal the competitive bidding program, in the Medicare Part B durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) program; S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011, this legislation expands transparency requirements for PBMs and limits certain audit practices by PBMs; H.R. 1936, the Medicare Access to Diabetes Act of 2011, legislation exempts small pharmacies from the DME competitive bidding program for diabetes test supplies; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011, would provide a narrow anti-trust exemption to allow small pharmacies to form pools to negotiate with PBMs; HR. 1409, the Quality Health Care Coalition Act of 2011, legislation would exempt health care professionals from federal antitrust laws for the purposes of contract negotiations with health plans; H.R. 1839, the Community Pharmacy Fairness Act, legislation would provide a narrow anti-trust exemption, which would allow groups of independent pharmacies to negotiate PBM contracts; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program, and for other purposes; Worked with Senate Finance and House Energy and Commerce staff on addressing questions raised by GAO regarding a study being conducted on the 3408 drug program as well as educating staff on the current 340b program; Sought Congressional support for the FTC investigation of the merger between two major national PBMs; H.R. 1540 and S. 1253, the National Defense Authorization Act for FY 12, includes funding for the TRICARE pharmacy program… | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE | 178134 | 0 | 0 | 2011-10-17T16:13:34.810000-04:00 | |
| 1152032 | LOCKE LORD PUBLIC POLICY GROUP LLC 3b475ca8-409f-415e-b0c9-938c6411cbc8 | Q3 | LOCKE LORD PUBLIC POLICY GROUP LLC | 300971 | MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES | 2011 | third_quarter | PHA | Pharmceutical performance reimbursement; biogenics | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-17T17:30:12.213000-04:00 | |
| 1152294 | RUBICON ADVISORS, LLC daf93488-a19c-4038-bf45-6a2da917b9bc | Q3 | RUBICON ADVISORS, LLC | 315091 | GILEAD SCIENCES | 2011 | third_quarter | PHA | H.R. 822, H.R. 1943, H.R. 6114, S-2969 | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2011-10-17T19:51:44.363000-04:00 | |
| 1152295 | RUBICON ADVISORS, LLC fe0ef7e1-f242-4bde-889d-ae8efe059261 | Q3 | RUBICON ADVISORS, LLC | 315091 | TEVA PHARMACEUTICALS USA | 2011 | third_quarter | PHA | Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 105000 | 0 | 0 | 2011-10-17T20:01:44.877000-04:00 | |
| 1152296 | RUBICON ADVISORS, LLC 3ba1843b-7f49-4544-8cc5-da576d0d0fd4 | Q3 | RUBICON ADVISORS, LLC | 315091 | WATSON PHARMACEUTICALS INC | 2011 | third_quarter | PHA | Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 | HOUSE OF REPRESENTATIVES,SENATE | 98000 | 0 | 0 | 2011-10-17T20:06:45.467000-04:00 | |
| 1152297 | RUBICON ADVISORS, LLC d5322948-a8cd-48fb-a5b2-98d46e512d3c | 3T | RUBICON ADVISORS, LLC | 315091 | INSMED INCORPORATED | 2011 | third_quarter | PHA | Generic Biologics S. 1695 Affordable Health Care Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2011-10-17T20:10:46.057000-04:00 | ||
| 1152299 | RUBICON ADVISORS, LLC 12c41d8a-211a-4ade-9cb8-6427f5fbd1a0 | 3T | RUBICON ADVISORS, LLC | 315091 | OSMOTICA PHARMACEUTICALS | 2011 | third_quarter | PHA | FDA Citizen Petition Reform Affordable Healthcare Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2011-10-17T20:16:46.650000-04:00 | ||
| 1152300 | RUBICON ADVISORS, LLC 3aa9283a-6223-48d7-b5c8-f3506e2fdf47 | Q3 | RUBICON ADVISORS, LLC | 315091 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2011 | third_quarter | PHA | Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-17T20:21:47.243000-04:00 | |
| 1152301 | RUBICON ADVISORS, LLC b2f569f3-4540-4336-b479-3f7594779777 | 3T | RUBICON ADVISORS, LLC | 315091 | CHILDREN'S HOSPITAL AND RESEARCH CENTER | 2011 | third_quarter | PHA | Health Care | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2011-10-17T20:26:48.447000-04:00 | ||
| 1152765 | FAEGRE BAKER DANIELS CONSULTING 300e5b70-55b8-493f-bd39-5311f998f0a2 | Q3 | FAEGRE BAKER DANIELS CONSULTING | 34158 | ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) | 2011 | third_quarter | PHA | ONLINE PHARMACIES | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-18T09:35:45.433000-04:00 | |
| 1152910 | MCDERMOTT WILL & SCHULTE LLP 460799c1-9fe4-44af-bab8-e031450f4918 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2011 | third_quarter | PHA | Issues related to Section 340B of the Public Health Service Act. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-18T10:07:40.283000-04:00 | |
| 1153168 | MCDERMOTT WILL & SCHULTE LLP fbd18a4d-7393-4cd4-bd7f-0ba0ebd0ace5 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2011 | third_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 95000 | 0 | 0 | 2011-10-18T10:38:27.603000-04:00 | |
| 1153241 | THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA 795ce075-8198-49f7-bcb1-5c105b5ba169 | Q3 | THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA | 18672 | HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA | 2011 | third_quarter | PHA | S. 296, Preserving Access to Life-Saving Medications H.R. 2245, Preserving Access to Life-Saving Medications Act of 2011 | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2011-10-18T10:49:00.667000-04:00 | |
| 1153295 | STRATEGIES 360 b489989a-4841-4128-876d-843f77257d68 | Q3 | STRATEGIES 360 | 79175 | MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES | 2011 | third_quarter | PHA | Drug Utilization Review Program, Competitive bidding, HR 5597: Medicare Patient IVIG Access Demonstration Project, Medical Loss Ratio, Performance-Based Pharmacy Reimbursement, PDUFA & Biosimilars, | Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-18T10:56:24.887000-04:00 | |
| 1153336 | EISAI INC. 925f7618-5274-4581-ba80-eb6536eb0c3e | Q3 | EISAI INC. | 400321512 | EISAI INC. | 2011 | third_quarter | PHA | Prescription Drug User Fee Act reauthorization. FDA-DEA issues Maintain current 340B program Maintain current exclusivity period for innovator biologics | Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 785000 | 0 | 0 | 2011-10-18T11:02:46.637000-04:00 | |
| 1153703 | BLUECROSS BLUESHIELD OF TENNESSEE 69cfe056-e3b6-4872-b27b-9eabc88ff37d | Q3 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2011 | third_quarter | PHA | General Pharmacy Issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-18T12:05:15.947000-04:00 | |
| 1154188 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2494dd9d-17e5-4b37-bc94-94c9f2c33ecd | Q3 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 58534 | ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 2011 | third_quarter | PHA | HR 2674 Supportive of any language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers by expanding 340B discounts to inpatient settings. | HOUSE OF REPRESENTATIVES,SENATE | 71787 | 0 | 0 | 2011-10-18T13:30:21.100000-04:00 | |
| 1154523 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) a8272b56-8adb-472a-be5b-ab2226c438cb | Q3 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2011 | third_quarter | PHA | Importationof prescription drugs (S.319, H.R. 147), Rx Pedigree (H.R. 3026), Methamphetamine/Pseudoephedrine Regulation, NASPER Reauthorization (H.R. 866), Pill Mill Crackdown Act (H.R. 1065), Drug Abuse (S.507), Drug Shortages (S. 296/H.R. 2245), Cargo/Product Theft (S. 1002), Import Safety (S. 1584) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 264000 | 0 | 0 | 2011-10-18T14:18:44.467000-04:00 | |
| 1154611 | UNIVERSITY OF CONNECTICUT f38e285b-99dc-4705-af40-8aaced6cc0dd | Q3 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2011 | third_quarter | PHA | FDA salaries and expense; and extramural research related issues: H.R. 2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-10-18T14:28:20.667000-04:00 | |
| 1154627 | MCDERMOTT WILL & SCHULTE LLP 0e66da02-3012-4a12-9b4c-ceab8527cda8 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ISIS PHARMACEUTICALS | 2011 | third_quarter | PHA | Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-10-18T14:31:28.007000-04:00 | |
| 1154933 | EMPIRE CONSULTING GROUP 3910e32a-af0d-43b4-8154-3c706f4ecb22 | Q3 | EMPIRE CONSULTING GROUP | 400703105 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2011 | third_quarter | PHA | Proposals relating to Medicare Part D; proposals relating to the Independent Payment Advisory Board ("IPAB"); and "super committee" deficit reductions proposals. | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2011-10-18T14:59:23.710000-04:00 | |
| 1154941 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c44b8a0d-b4bd-4cc5-b910-18881cc75177 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | THE HEMOPHILIA ALLIANCE | 2011 | third_quarter | PHA | Issues realted to the 340B drug discount program. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-18T15:00:27.523000-04:00 | |
| 1155013 | WINSTON & STRAWN LLP 8125d281-4704-4305-a7c7-37f9242bb8c0 | Q3 | WINSTON & STRAWN LLP | 41682 | FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) | 2011 | third_quarter | PHA | Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. Legislation of interest includes the America Invents Act of 2011 (H.R. 1249). | HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2011-10-18T15:06:00.037000-04:00 | |
| 1155178 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2ffc6f6a-d92f-493c-baa2-e275c9c68035 | Q3 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 4653 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 2011 | third_quarter | PHA | FDA proposals to change the requirements for the "major statement" in direct to consumer prescription drug advertisements Comments to FDA on proposal regarding disclosures for online prescription drug advertising | Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 280000 | 0 | 0 | 2011-10-18T15:17:07.943000-04:00 | |
| 1155186 | THE UNITED STATES PHARMACOPEIAL CONVENTION 4c784ef0-65db-4606-a869-42c4dea51550 | Q3 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 400358632 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 2011 | third_quarter | PHA | - Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients. | Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-10-18T15:18:10.287000-04:00 | |
| 1155450 | BROWN RUDNICK LLP 595242a1-eac0-4041-af00-5da16eb817a5 | Q3 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2011 | third_quarter | PHA | Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-18T15:43:10.633000-04:00 | |
| 1157149 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION e46ea49c-fc74-49f2-b420-609bb1255c61 | Q3 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2011 | third_quarter | PHA | Over-the-Counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA H.R. 1483 - Drug Safety Enhancement Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand drug establishment registration requirements to include foreign drug establishments and other purposes; all sections. | HOUSE OF REPRESENTATIVES,SENATE | 205000 | 0 | 0 | 2011-10-19T09:32:25.423000-04:00 | |
| 1157211 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP 4d20993c-d808-49f7-9dd9-cafe8fca8e8a | Q3 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP | 30187 | GENENTECH | 2011 | third_quarter | PHA | Monitor Drug Safety and pedigree legislation | Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-10-19T09:41:47.640000-04:00 | |
| 1157364 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP 2fa46219-a6b9-4517-998a-60fe9cb124f2 | Q3 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP | 30187 | NOVO NORDISK | 2011 | third_quarter | PHA | P.L. 111-148- Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152- The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2011-10-19T10:08:50.343000-04:00 | |
| 1157647 | NATIONAL RURAL HEALTH ASSOCATION eaffe4bf-0379-4be4-b698-28d62b4d4c02 | Q3 | NATIONAL RURAL HEALTH ASSOCATION | 53048 | NATIONAL RURAL HEALTH ASSOCATION | 2011 | third_quarter | PHA | Support for 340B drug program, expansion in health reform, and implementation. | Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 11424 | 0 | 0 | 2011-10-19T10:44:33.463000-04:00 | |
| 1158057 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES 0bf76cac-39be-450c-864c-37c29841dcff | Q3 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2011 | third_quarter | PHA | S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 S.1356, Affordable Medicines Utilization Act of 2011 S.1584, Drug Safety and Accountability Act of 2011 H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011 | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE | 440000 | 0 | 0 | 2011-10-19T11:35:19.773000-04:00 | |
| 1158162 | ELI LILLY AND COMPANY 50b6b86e-4873-4e83-a5b8-6fa4fd02adaf | Q3 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2011 | third_quarter | PHA | Hospital discounts (HR 3590) | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office | 2325000 | 0 | 0 | 2011-10-19T11:58:00.710000-04:00 | |
| 1158166 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP 2fcb9bbd-583b-48c6-aa81-9931c8ab531e | Q3 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP | 30187 | ALTRIA CLIENT SERVICES INC | 2011 | third_quarter | PHA | Prescription Drug User Fee Act (PDUFA) reauthorization. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-10-19T11:58:01.680000-04:00 | |
| 1158931 | UNIVERSITY OF IOWA f7adc2b8-4875-4e08-8fc9-b8b1f0df246b | Q3 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2011 | third_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 88684 | 0 | 0 | 2011-10-19T14:29:01.677000-04:00 | |
| 1159029 | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC badcedab-d477-4f82-ac6c-a16ead251830 | Q3 | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 292972 | BOEHRINGER INGELHEIM USA CORPORATION | 2011 | third_quarter | PHA | Reauthorization of the Prescription Drug User Fee Act; Drug Safety | HOUSE OF REPRESENTATIVES,SENATE | 530000 | 0 | 0 | 2011-10-19T14:34:46.067000-04:00 | |
| 1159405 | MARSHFIELD CLINIC HEALTH SYSTEM 35e3185b-0dc2-470e-9ee2-a2eff0499d85 | Q3 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2011 | third_quarter | PHA | Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE | 130000 | 0 | 0 | 2011-10-19T14:51:09.190000-04:00 | |
| 1159587 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 0052a5d9-9364-42de-9b3a-51c1b26ee06f | Q3 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2011 | third_quarter | PHA | Comments to the Health Resources and Services Administration on the 340B Drug Discount Program and the procurement of orphan drugs under the program. Submitted letter of support for H.R. 2674, the 340B Improvement Act of 2011. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 250000 | 0 | 0 | 2011-10-19T15:02:23.783000-04:00 | |
| 1159612 | BUCHANAN INGERSOLL & ROONEY PC 49e249c4-4678-49d8-a394-4bc82890c6be | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GENERIC ANIMAL DRUG ALLIANCE | 2011 | third_quarter | PHA | Legislative issues relating to United States Food & Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-19T15:03:32.720000-04:00 | ||
| 1159887 | HANCE SCARBOROUGH 79abd5cc-bc7f-44d2-abb3-f9eabf062c3f | Q3 | HANCE SCARBOROUGH | 17443 | INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) | 2011 | third_quarter | PHA | Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-19T15:16:13.017000-04:00 | |
| 1160208 | HANCE SCARBOROUGH 246d7954-0e5d-4bef-ba4b-da4ff85b5985 | Q3 | HANCE SCARBOROUGH | 17443 | TEXAS ACADEMY OF COMPOUNDING PHARMACISTS | 2011 | third_quarter | PHA | Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-19T15:32:24.903000-04:00 | |
| 1160514 | WHITMER & WORRALL, LLC ab3ec5d8-8464-48b9-9aee-ce1139dedda0 | Q3 | WHITMER & WORRALL, LLC | 292892 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2011 | third_quarter | PHA | Issues related to monitoring healthcare reform. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-19T15:47:23.813000-04:00 | |
| 1160698 | DOW LOHNES GOVERNMENT STRATEGIES LLC b09d8f56-69a0-4ae3-ac0f-171400fe80c6 | Q3 | DOW LOHNES GOVERNMENT STRATEGIES LLC | 316013 | AMERISOURCEBERGEN CORPORATION | 2011 | third_quarter | PHA | Legislative proposals related to pharmaceutical pedigree anti-counterfeiting, wholesale transaction documentation, and electronic tracking, including H.R. 1483, H.R. 3026, and S. 1584; legislative proposals related to drug shortages, including H.R. 2245 and S. 296. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-19T15:56:34.610000-04:00 | |
| 1160860 | BUCHANAN INGERSOLL & ROONEY PC 304a23cf-0fc4-41fe-9371-1896d1413c3c | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | IPEC - AMERICAS, INC. | 2011 | third_quarter | PHA | FDA Globalization Acts and legislation related to supply chain security and drug contamination issues | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-19T16:08:35.907000-04:00 | |
| 1160870 | THE RUSSELL GROUP, INC. 67be1fa0-4883-47cf-85d1-57f7c4d36ec0 | Q3 | THE RUSSELL GROUP, INC. | 22688 | GENERIC PHARMACEUTICAL ASSOCIATION | 2011 | third_quarter | PHA | Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011). | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 50000 | 0 | 0 | 2011-10-19T16:09:40.407000-04:00 | |
| 1160885 | BUCHANAN INGERSOLL & ROONEY PC 6a850300-2adf-4ab6-a01b-80704149c0fa | Q3 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO | 2011 | third_quarter | PHA | Patent reform, drug importation; Life Science Investment Act; drug exception from Pharma fee; medical device tax. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-19T16:11:47.483000-04:00 | |
| 1161037 | 340B HEALTH d4fe6c2b-72aa-448a-9977-b228c4994dfe | Q3 | 340B HEALTH | 316434 | 340B HEALTH | 2011 | third_quarter | PHA | Advocating for the passage of H.R. 2674. Extending 340B drug discount program to the inpatient setting in eligible hospitals. Improving program integrity. Ensuring adequate reimbursement to 340B covered entities from third party payers. Reversing 340B orphan drug discount prohibition for certain covered entities. | Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 221204 | 0 | 0 | 2011-10-19T16:25:36.810000-04:00 | |
| 1161112 | ASSOCIATION FOR ACCESSIBLE MEDICINES a3628046-2bcc-47fc-9afd-7070ec87dab5 | Q3 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 16032 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 2011 | third_quarter | PHA | FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011 | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office | 548315 | 0 | 0 | 2011-10-19T16:34:06.983000-04:00 | |
| 1161296 | ASTRAZENECA PHARMACEUTICALS LP 152ed980-6806-4a2f-8c52-35afe3714aa7 | Q3 | ASTRAZENECA PHARMACEUTICALS LP | 54073 | ASTRAZENECA PHARMACEUTICALS LP | 2011 | third_quarter | PHA | HR 2112, HR 2190, S1206 - Proposed legislation regarding FDA appropriations FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) (no bill number yet) | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office | 1410000 | 0 | 0 | 2011-10-19T16:50:11.387000-04:00 | |
| 1161423 | GENZYME CORPORATION c35077b4-db9d-49d2-acd1-6235f11bf924 | Q3 | GENZYME CORPORATION | 16054 | GENZYME CORPORATION | 2011 | third_quarter | PHA | S.606/H.R. 3059 - Creating Hope Act of 2011 Prescription Drug User Fee Act Reauthorization S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act H.R. 2482, Drug Safety Enhancement Act | HOUSE OF REPRESENTATIVES,SENATE | 460000 | 0 | 0 | 2011-10-19T17:06:11.277000-04:00 | |
| 1161911 | UPS (UNITED PARCEL SERVICE) adaf6f7e-418b-41ad-94b3-4f944896e54f | Q3 | UPS (UNITED PARCEL SERVICE) | 39223 | UPS (UNITED PARCEL SERVICE) | 2011 | third_quarter | PHA | - S.1984/HR 3026 FDA Track and Trace - Pedigree - Serialization | Commerce, Dept of (DOC),Defense, Dept of (DOD),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office | 978161 | 0 | 0 | 2011-10-19T17:58:45.507000-04:00 | |
| 1162316 | C2 GROUP, LLC e9f77976-2fa2-4414-8a64-3a1b27304d7b | Q3 | C2 GROUP, LLC | 66693 | PERRIGO INC | 2011 | third_quarter | PHA | OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-19T19:00:06.377000-04:00 | |
| 1162410 | OMNICARE, INC. 9a6a9018-a345-4524-a9e6-4de3abef345c | Q3 | OMNICARE, INC. | 321112 | OMNICARE INC | 2011 | third_quarter | PHA | Encouraging consideration of SB 1560; related to ensuring access to pain medication to nursing home residents. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2011-10-19T19:29:12.517000-04:00 | |
| 1162451 | KNIGHT CAPITOL CONSULTANTS b70aa75d-d846-471d-a40e-6c529cc35d4a | Q3 | KNIGHT CAPITOL CONSULTANTS | 40036301 | GENZYME CORPORATION | 2011 | third_quarter | PHA | S. 606, Creating Hope Act of 2011 S. 296/H.R. 2245, Preserving Access to Life-Saving Medication Act Reauthorization of the Prescription Drug User Fee Act and possible amendments thereto (no legislation yet) | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-19T19:42:32.737000-04:00 | |
| 1162562 | SHIRE PHARMACEUTICALS LLC 3890b669-0f7c-4af0-aeb2-2d65bbd7cba3 | Q3 | SHIRE PHARMACEUTICALS LLC | 323477 | SHIRE PHARMACEUTICALS LLC | 2011 | third_quarter | PHA | Life Sciences Investment Act; orphan drugs; end stage renal disease (ESRD) bundling of non-injectable oral equivalents; ESRD Quality Incentive program; Prescription Drug User Fee program; reimbursements; drug shortages; DEA quotas | SENATE | 80000 | 0 | 0 | 2011-10-19T20:14:18.343000-04:00 | |
| 1162886 | SQUIRE PATTON BOGGS (US) LLP (F.K.A. SQUIRE SANDERS (US) LLP) e6b14fae-9334-4377-a1d4-2820bfa7aa7c | Q3 | SQUIRE PATTON BOGGS (US) LLP (F.K.A. SQUIRE SANDERS (US) LLP) | 55223 | COVERMYMEDS | 2011 | third_quarter | PHA | Prescription drug prior authorizations and other insurance coverage determinations. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS) | 30000 | 0 | 0 | 2011-10-19T22:33:18.207000-04:00 | |
| 1162975 | KAR ASSOCIATES, LLC 58f68964-6fe5-4105-a273-b4d34956931f | Q3 | KAR ASSOCIATES, LLC | 45015 | EMERGENCY NURSES ASSN | 2011 | third_quarter | PHA | S. 296, Drug Shortage Bill | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-20T02:44:59.323000-04:00 | |
| 1163129 | VAN SCOYOC ASSOCIATES 0fbc6ff5-46d2-4865-80f0-6bf1adaaf649 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF CONNECTICUT | 2011 | third_quarter | PHA | FDA salaries and expenses; and extramural research related issues: H.R.2112,Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-20T05:58:37.960000-04:00 | |
| 1163140 | VAN SCOYOC ASSOCIATES ec8d98c8-b5cd-4d80-b8e3-d654952a8cc6 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE | 2011 | third_quarter | PHA | FDA funding initiatives; Critical Path Partnership. H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-20T05:58:39.163000-04:00 | |
| 1163145 | VAN SCOYOC ASSOCIATES 91a650d9-a725-4d60-88d0-c7f0e4e90dd0 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF MARYLAND BALTIMORE | 2011 | third_quarter | PHA | No lobbying activity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2011-10-20T05:58:41.053000-04:00 | |
| 1163189 | BLUESTONE STRATEGIES, LLC e1afc06d-2d1d-44ca-8a3b-5847efed210b | Q3 | BLUESTONE STRATEGIES, LLC | 400658980 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2011 | third_quarter | PHA | Pharmacy Act; Drug Reimportation; Generic Brand Settlement; Generic Dispensing; Generic Biologics; and Specialty Drug Issues. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-20T07:24:38.460000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);